Nevertheless, the differential expression of EGFR and VEGFc, in addition to MMP9 and CXCL5, differentially packaging into IRF5-low versus IRF5-high EVs across two cancer types provide insight into the mechanisms by which IRF5 contributes to protection from PMN formation. This evidence concerns the gene IRF5 and cancer.